Education
About Us
Working with TipRanks
Follow Us
Amarin Corporation Plc (AMRN)
NASDAQ:AMRN
AMRN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.35 - $1.11
Previous CloseN/A
Volume726.09K
Average Volume (3M)1.76M
Market Cap
$188.14M
Enterprise Value-$40.29M
Total Cash (Recent Filing)$121.04M
Total Debt (Recent Filing)$7.72M
Price to Earnings (P/E)―
Beta1.48
Next Earnings
Apr 30, 2025EPS Estimate
-0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.20
Shares Outstanding414,186,300
10 Day Avg. Volume3,520,365
30 Day Avg. Volume1,759,495
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.83
Price to Cash Flow (P/CF)-3.60
P/FCF Ratio0.00
Enterprise Value/Market Cap-0.21
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-0.50
Enterprise Value/Ebitda0.54
Forecast
1Y Price Target
$1.00Price Target Upside117.39% Upside
Rating ConsensusHold
Number of Analyst Covering1
---
Bulls Say, Bears Say
Bulls Say
Financial StabilityAmarin maintained a stable cash position of $294M in 4Q24 with no debt.
International Market ExpansionAmarin secured additional pricing and reimbursement agreements in Europe, with Italy showing progress with access being secured in 9 regions (>50% of eligible market).
Bears Say
Competitive PressureThe US Vascepa franchise continues to face significant competitive pressure from at least 8 generic competitors, with gross margins declining to 41% in 4Q24 vs 58% in 4Q23.
Market Access ChallengesVazkepa's EU launch remains slower than expected due to continued market access challenges, which is an overhang on the stock.
---
Ownership Overview
0.43% Insiders
0.18% Mutual Funds
12.46% Other Institutional Investors
86.71% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AMRN FAQ
What was Amarin Corporation Plc’s price range in the past 12 months?
Amarin Corporation Plc lowest stock price was $0.35 and its highest was $1.11 in the past 12 months.
What is Amarin Corporation Plc’s market cap?
Amarin Corporation Plc’s market cap is $188.14M.
When is Amarin Corporation Plc’s upcoming earnings report date?
Amarin Corporation Plc’s upcoming earnings report date is Apr 30, 2025 which is in 36 days.
How were Amarin Corporation Plc’s earnings last quarter?
Amarin Corporation Plc released its earnings results on Mar 12, 2025. The company reported -$0.12 earnings per share for the quarter, missing the consensus estimate of -$0.053 by -$0.067.
Is Amarin Corporation Plc overvalued?
According to Wall Street analysts Amarin Corporation Plc’s price is currently Undervalued.
Does Amarin Corporation Plc pay dividends?
Amarin Corporation Plc does not currently pay dividends.
What is Amarin Corporation Plc’s EPS estimate?
Amarin Corporation Plc’s EPS estimate is -0.04.
How many shares outstanding does Amarin Corporation Plc have?
Amarin Corporation Plc has 414,186,300 shares outstanding.
What happened to Amarin Corporation Plc’s price movement after its last earnings report?
Amarin Corporation Plc reported an EPS of -$0.12 in its last earnings report, missing expectations of -$0.053. Following the earnings report the stock price went down -14.894%.
Which hedge fund is a major shareholder of Amarin Corporation Plc?
Currently, no hedge funds are holding shares in AMRN
---
Amarin Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$1.00 (117.39% Upside)
$1.00 (117.39% Upside)
Blogger Sentiment
Bullish
AMRN Sentiment 100%
Sector Average 69%
Sector Average 69%
Crowd Wisdom
Positive
Last 7 Days ▲ 0.4%
Last 30 Days ▲ 0.9%
Last 30 Days ▲ 0.9%
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-46.92%
12-Months-Change
Fundamentals
Return on Equity
-15.79%
Trailing 12-Months
Asset Growth
-17.59%
Trailing 12-Months
Company Description
Amarin Corporation Plc
Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.
---
AMRN Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture. While Amarin demonstrated strong financial foundation, global expansion progress, and effective cost management, significant challenges persist in the U.S. market due to generic competition, resulting in a revenue decline and increased net loss. The commitment to research and development offers potential future growth opportunities.Read More>---
AMRN Stock 12 Month Forecast
Average Price Target
$1.00
▲(117.39% Upside)
Technical Analysis
Best Analysts Covering AMRN
1 Year
1 Year Success Rate
11/12 ratings generated profit
1 Year Average Return
+32.29%
reiterated a sell rating 8 months ago
Copying Paul Choi's trades and holding each position for 1 Year would result in 91.67% of your transactions generating a profit, with an average return of +32.29% per trade.
---